Status:
COMPLETED
The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata
Lead Sponsor:
University of British Columbia
Conditions:
Alopecia Areata
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Alopecia areata (AA) is a disease characterized by areas of hair loss. Localized steroid injections is the standard treatment for limited disease. There are no existing studies that compare different ...
Detailed Description
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss with varying degree of severity. It most commonly involves scalp hair. It was estimated to occur in 0.1% to 0.2% of...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Less than 50% scalp involvement
- Patients should have a patch of at least 4.5 cm in the smallest diameter
Exclusion
- Current episode of alopecia areata for longer than 2 years
- Evidence of hair regrowth at baseline
- Patients who received treatment with a topical, intralesional, or systemic agent within the past month
- Rapidly progressing disease
- Hypersensitivity to Triamcinolone acetonide or vehicle
- Pregnancy or breast-feeding
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01246284
Start Date
December 1 2010
End Date
July 1 2014
Last Update
June 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Skin Care Center, Vancouver General Hospital, 835 West 10th Ave
Vancouver, British Columbia, Canada